Free Trial
CVE:HIV

HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis

HIVE Blockchain Technologies logo

About HIVE Blockchain Technologies Stock (CVE:HIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive HIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.

HIV Stock News Headlines

What is B. Riley's Estimate for CVE:HIV Q1 Earnings?
Roth Capital Issues Optimistic Estimate for CVE:HIV Earnings
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

HIV Stock Analysis - Frequently Asked Questions

HIVE Blockchain Technologies Ltd. (CVE:HIV) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.04.

Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HIVE Blockchain Technologies investors own include ProShares Bitcoin ETF (BITO), Meta Platforms (META), Broadcom (AVGO), Marathon Digital (MARA), NVIDIA (NVDA), Riot Platforms (RIOT) and Shopify (SHOP).

Company Calendar

Last Earnings
11/12/2024
Today
7/19/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Services – Management, Public Relations, Consulting
Sub-Industry
Business Services
Current Symbol
CVE:HIV
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (CVE:HIV) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners